|Articles|November 27, 2021

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer.

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options. A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer. Read more in our XRAY review. #helpnothype #BehindtheCancerHeadlines

Related to this article

mammogram
Long-term Kisqali data, a new targeted drug, blood tests and AI are among the topics to watch at the 2026 San Antonio Breast Cancer Symposium.